Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases

키워드

참고문헌 (71)

1. Falkinham JO 3rd, "Nontuberculous mycobacteria in the environment", Clin Chest Med, 23, pp.529~551 (2002)
2. Simons S, "Nontuberculous mycobacteria in respiratory tract infections, eastern Asia", Emerg Infect Dis, 17, pp.343~349 (2011)
3. Prevots DR, "Epidemiology of human pulmonary infection with nontuberculous mycobacteria : a review", Clin Chest Med, 36, pp.13~34 (2015)
4. Hermansen TS, "Nontuberculous mycobacteria in Denmark, incidence and clinical importance during the last quarter-century", Sci Rep, 7, pp.6696~ (2017)
5. Smith GS, "Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010", J Infect, 72, pp.678~686 (2016)
6. Henkle E, "Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007-2012", Emerg Infect Dis, 23, pp.1627~1630 (2017)
7. Blanc P, "Nontuberculous mycobacterial infections in a French hospital: a 12-year retrospective study", PLoS One, 11, pp.e0168290~ (2016)
8. Brode SK, "Pulmonary versus nonpulmonary nontuberculous mycobacteria, Ontario, Canada", Emerg Infect Dis, 23, pp.1898~1901 (2017)
9. Griffith DE, "An official ATS", IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial disease, 2007, pp.175, 367~416
10. Holt MR, "Management of extrapulmonary nontuberculous mycobacterial infections", Semin Respir Crit Care Med, 39, pp.399~410 (2018)
11. Piersimoni C, "Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons", Emerg Infect Dis, 15, pp.1351~1358 (2009)
12. Wentworth AB, "Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study", Mayo Clin Proc, 88, pp.38~45 (2013)
13. Allen KB, "Nontuberculous mycobacterium infections associated with heater-cooler devices", Ann Thorac Surg, 104, pp.1237~1242 (2017)
14. Chand M, "Insidious risk of severe Mycobacterium chimaera infection in cardiac surgery patients", Clin Infect Dis, 64, pp.335~342 (2017)
15. 김남희, "Recovery Rates of Non-Tuberculous Mycobacteria from Clinical Specimens Are Increasing in Korean Tertiary-Care Hospitals", Journal of Korean Medical Science, 32(8), pp.1263~1267 (2017), 대한의학회
16. Cheng A, "Prolonged postprocedural outbreak of Mycobacterium massiliense infections associated with ultrasound transmission gel", Clin Microbiol Infect, 22, pp.382.e1~382.e11 (2016)
17. Rodriguez JM, "Mycobacterium chelonae facial infections following injection of dermal filler", Aesthet Surg J, 33, pp.265~269 (2013)
18. Ivan M, "Mycobacterium chelonae abscesses associated with biomesotherapy, Australia, 2008", Emerg Infect Dis, 19, pp.1493~1495 (2013)
19. Galmés-Truyols A, "An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy", Enferm Infecc Microbiol Clin, 29, pp.510~514 (2011)
20. Koh SJ, "An outbreak of skin and soft tissue infection caused by Mycobacterium abscessus following acupuncture", Clin Microbiol Infect, 16, pp.895~901 (2010)
21. Uslan DZ, "Skin and soft tissue infections due to rapidly growing mycobacteria", Arch Dermatol, 142, pp.1287~1292 (2006)
22. Winthrop KL, "An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon", N Engl J Med, 346, pp.1366~1371 (2002)
23. Strnad L, "Treatment of Mycobacterium abscessus complex", Semin Respir Crit Care Med, 39, pp.362~376 (2018)
24. Shen GH, "High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria", Int J Antimicrob Agents, 35, pp.400~404 (2010)
25. van Ingen J, "In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease", Antimicrob Agents Chemother, 56, pp.6324~6327 (2012)
26. Ferro BE, "Clofazimine prevents the regrowth of Mycobacterium abscessus and Mycobacterium avium type strains exposed to amikacin and clarithromycin", Antimicrob Agents Chemother, 60, pp.1097~1105 (2015)
27. Esteban J, "Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria", Clin Microbiol Infect, 15, pp.919~923 (2009)
28. Koh WJ, "Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus", Am J Respir Crit Care Med, 183, pp.405~410 (2011)[DOI]
29. Stout JE, "Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others", Am J Respir Crit Care Med, 186, pp.822~823 (2012)
30. Choi GE, "Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance", Am J Respir Crit Care Med, 186, pp.917~925 (2012)
31. Duarte RS, "Epidemic of postsurgical infections caused by Mycobacterium massiliense", J Clin Microbiol, 47, pp.2149~2155 (2009)
32. Goldman J, "Infections from tattooing. Outbreak of Mycobacterium chelonae in France", BMJ, 341, pp.c5483~ (2010)
33. Kennedy BS, "Outbreak of Mycobacterium chelonae infection associated with tattoo ink", N Engl J Med, 367, pp.1020~1024 (2012)
34. Winthrop KL, "The clinical management and outcome of nail salon-acquired Mycobacterium fortuitum skin infection", Clin Infect Dis, 38, pp.38~44 (2004)
35. Johnson MG, "Twenty-eight cases of Mycobacterium marinum infection : retrospective case series and literature review", Infection, 43, pp.655~662 (2015)
36. Sia TY, "Clinical and pathological evaluation of Mycobacterium marinum group skin infections associated with fish markets in New York City", Clin Infect Dis, 62, pp.590~595 (2016)
37. Clinical and Laboratory Standards Institute (CLSI), "Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes. Approved standard. 2nd ed. M24-A2", CLSI, ~ (2011)
38. Huang Y, "Successful treatment of refractory cutaneous infection caused by Mycobacterium marinum with a combined regimen containing amikacin", Clin Interv Aging, 7, pp.533~538 (2012)
39. Hisamichi K, "Efficacy of oral minocycline and hyperthermic treatment in a case of atypical mycobacterial skin infection by Mycobacterium marinum", J Dermatol, 29, pp.810~811 (2002)
40. Yotsu RR, "Revisiting Buruli ulcer", J Dermatol, 42, pp.1033~1041 (2015)
41. World Health Organization (WHO), "Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer)", WHO, ~ (2004)
42. Friedman ND, "Increasing experience with primary oral medical therapy for Mycobacterium ulcerans disease in an Australian cohort", Antimicrob Agents Chemother, 60, pp.2692~2695 (2016)
43. World Health Organization (WHO), "Treatment of Mycobacterium ulcerans disease (Buruli ulcer): Guidance for health workers", WHO, ~ (2012)
45. Lee MR, "Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008-2014", Int J Antimicrob Agents, 50, pp.35~40 (2017)
46. Xu HB, "Treatment outcomes for Mycobacterium avium complex : a systematic review and meta-analysis", Eur J Clin Microbiol Infect Dis, 33, pp.347~358 (2014)
47. Bi S, "Nontuberculous mycobacterial osteomyelitis", Infect Dis(Lond), 47, pp.673~685 (2015)
48. Goldstein N, "Nontuberculous mycobacterial musculoskeletal infection cases from a tertiary referral center, Colorado, USA", Emerg Infect Dis, 25, pp.1075~1083 (2019)
49. Park JW, "Non-tuberculous mycobacterial infection of the musculoskeletal system : pattern of infection and efficacy of combined surgical", antimicrobial treatment, 2014, pp.96, 1561~1565
50. Zenone T, "Non-tuberculous mycobacterial tenosynovitis : a review", Scand J Infect Dis, 31, pp.221~228 (1999)
51. Johnson MG, "Twenty-eight cases of Mycobacterium marinum infection : retrospective case series and literature review", Infection, 43, pp.655~662 (2015)
52. Lee EY, "Recurrent Mycobacterium marinum tenosynovitis of the wrist mimicking extraarticular synovial chondromatosis on MR images", Skeletal Radiol, 33, pp.405~408 (2004)
53. Smith DS, "Mycobacterium terrae: case reports, literature review, and in vitro antibiotic susceptibility testing", Clin Infect Dis, 30, pp.444~453 (2000)
54. Ingraham NE, "Prosthetic joint infection due to Mycobacterium avium-intracellulare in a patient with rheumatoid arthritis: a case report and review of the literature", Case Rep Infect Dis, 2017, pp.8682354~ (2017)
55. Eid AJ, "Prosthetic joint infection due to rapidly growing mycobacteria : report of 8 cases and review of the literature", Clin Infect Dis, 45, pp.687~694 (2007)
56. Henry MW, "Prosthetic joint infections secondary to rapidly growing mycobacteria : two case reports and a review of the literature", Infect Dis(Lond), 48, pp.453~460 (2016)
57. Kim CJ, "Vertebral osteomyelitis caused by nontuberculous mycobacteria : Predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature", Infect Dis(Lond), 48, pp.509~516 (2016)
58. Hogan JI, "Mycobacterial musculoskeletal infections", Infect Dis Clin North Am, 31, pp.369~382 (2017)
59. Haverkamp MH, "Nontuberculous mycobacterial infection in children : a 2-year prospective surveillance study in the Netherlands", Clin Infect Dis, 39, pp.450~456 (2004)
60. "Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association", Am J Respir Crit Care Med, 156, pp.S1~S5 (1997)
61. Thegerström J, "Pinpointing the source of infection of Mycobacterium avium hominissuis in children", Infect Dis(Lond), 49, pp.617~624 (2017)
62. Ding LW, "Lymphadenitis caused by non-tuberculous mycobacteria in a university hospital in Taiwan : predominance of rapidly growing mycobacteria and high recurrence rate", J Formos Med Assoc, 104, pp.897~904 (2005)
63. Hassell M, "Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts", Eur J Clin Microbiol Infect Dis, 20, pp.889~891 (2001)
64. Lindeboom JA, "Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial", Clin Infect Dis, 44, pp.1057~1064 (2007)
65. Lindeboom JA, "Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children", Pediatr Infect Dis J, 28, pp.1028~1030 (2009)
66. Tumbarello M, "Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies", Eur J Clin Microbiol Infect Dis, 20, pp.498~501 (2001)
67. Chaisson RE, "Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team", Ann Intern Med, 121, pp.905~911 (1994)
68. Dubé MP, "A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycinbased combination therapy. California Collaborative Treatment Group", J Infect Dis, 176, pp.1225~1232 (1997)
69. Benson CA, "A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome", Clin Infect Dis, 37, pp.1234~1243 (2003)
70. Kaplan JE, "Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America", MMWR Recomm Rep, 58, pp.1~207 (2009)
71. Brode SK, "Increased risk of mycobacterial infections associated with anti-rheumatic medications", Thorax, 70, pp.677~682 (2015)

관련 논문AI추천